Skip to main content
News Netea 10.2021
left: Prof. Dr. Mihai G. Netea; right: Prof. Dr. Andreas Schlitzer
© Mihai Netea / Uni Bonn

Publication

Epigenetics: Immunization is passed on to offspring

Adaptations to infection shown to be passed on over several generations in mice

Does an infection affect the immunity of subsequent generations? Prof. Andeas Schlitzer, member of ImmunoSensation2 and the Life & Medical Sciences Institute (LIMES) at the University of Bonn, Prof. Dr. Mihai G. Netea from Radboud University (Netherlands), together with researchers from Saarland University, Lausanne (Switzerland) and Athens (Greece), have investigated this. Mouse sires that either had previously overcome infection with fungi or were stimulated with fungal substances, passed on their improved protection over several generations. The team simultaneously demonstrated an improved immune response that was passed on to the offspring. The study has now been published in Nature Immunology.

The scientists infected male mice with thrush fungi (Candida albicans). After surviving the infection, the animals were mated with completely healthy females. The researchers compared the resulting children with offspring from pairs of mice that had not previously been infected with Candida. To experimentally examine the status of the immune system, the team infected the males of the subsequent generation of mice with coliform bacteria. The offspring of the male mice previously exposed to Candida were found to be significantly better protected from subsequent E. coli infection than the offspring of the uninfected male mice. This effect was still evident in the next generation.


Publication

Natalie Katzmarski, Jorge Domínguez-Andrés, Branko Cirovic, Georgios Renieris, Eleonora Ciarlo, Didier Le Roy, Konstantin Lepikhov, Kathrin Kattler, Gilles Gasparoni, Kristian Händler, Heidi Theis, Marc Beyer, Jos W. M. van der Meer, Leo A. B. Joosten, Jörn Walter, Joachim L. Schultze, Thierry Roger, Evangelos J. Giamarellos-Bourboulis, Andreas Schlitzer, Mihai G. Netea: Transmission of trained immunity and heterologous resistance to infections across generations, Nature Immunology, DOI: 10.1038/s41590-021-01052-7.


Contact

Prof. Dr. Andreas Schlitzer

Quantitative Systembiologie

LIMES-Institut (Life and Medical Sciences Bonn)

Universität Bonn

Tel. +49 2287362847

E-Mail: andreas.schlitzer(at)uni-bonn.de


Prof. Dr. Mihai G. Netea

Radboud university medical center und
LIMES-Institut der Universität Bonn

Tel. +31 243618819

E-Mail: Mihai.Netea(at)radboudumc.nl

Related news

News Icon

Publication

Malaria Causes Permanent Damage to Phagocytes in the Spleen

—Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or “scavenger cells,” to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. The researchers have demonstrated that malaria infection causes permanent damage to resident CD163 macrophages in the spleen, which are responsible for cleaning the blood, recycling iron and communicating with other cells involved in the body’s immune response.
View entry
Tracking glioblastoma cell spread in human brain tissue

Publication

Core2Edge: How tumor cells conquer the brain

—Glioblastoma is an aggressive brain tumor that infiltrates deep into the surrounding brain tissue. Even after surgery, tumor cells remain in the brain and the tumor recurs. Bonn researchers have now developed Core2Edge, a model based entirely on human tissue that captures these hard-to-access infiltration zones at the tumor margin. The model enables investigation of the invasive front and direct assessment of new drug candidates in human tissue - without the need for animal testing. The study of the Brain Tumor Translational Research Group has now been published in Nature Protocols.
View entry
Mikrochip zur Wiederherstellung zentralen Sehvermögens bei fortgeschrittener Makuladegeneration.

Publication

Approval of a Novel Retinal Implant Technology

—A novel retinal implant is offering people with geographic atrophy the opportunity to regain part of their central vision for the first time. Geographic atrophy is a severe late stage of age-related macular degeneration. An international research team led by Prof. Frank G. Holz of the UKB and the University of Bonn demonstrated in an international clinical trial that the majority of participants experienced significant improvements in visual acuity. The novel retinal implant technology has now received approval for routine clinical use in Europe, making it available beyond clinical trials.
View entry

Back to the news overview